Gottlieb sees 2022 as COVID-19 'transition year,' despite omicron

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb said 2022 will still be a “transition year” for COVID-19 despite the omicron variant. “I still think this is going to be a transition year,” Gottlieb said on Tuesday in an…
Source: The Hill